Loss of SHP-1 expression in tumor-specific T cells or natural killer cells promoted immune response and antitumor function in a mouse model of disseminated leukemia (Stromnes et al., 2012; Viant et al., 2014). The gene discussed is NR0B2; the disease is neoplasm.